BLTE
BELITE BIO, INC
NASDAQ · Healthcare · Biotechnology · US
$150.28
+1.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 78.95x
- P/E 2028E
- 24.29x
- P/S forward
- 27.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.79x
- Price / sales
- —
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $6.1B
- EV / sales
- —
- EV / EBITDA
- -52.99x
- EV / EBIT
- -50.99x
- Market cap
- $6.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026